WALTHAM, Mass.--(BUSINESS WIRE)--Interleukin Genetics, Inc. (OTCQB: ILIU) announced today that CEO Lewis H. Bender will present at the 14th Annual BIO CEO & Investor Conference on Tuesday, February 14 at the Waldorf Astoria, in New York City. Mr. Bender will provide an overview of the Company and an update on the PST clinical study at 1:30 p.m. (EST) in the Hotel’s Park South room, located on the fourth floor. Mr. Bender will be available for one-on-one meetings with investors participating in BIO CEO before and after his presentation.
